MVX-ONCO-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVX-ONCO-2, covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: MVX-ONCO-2 in Advanced Solid Tumors [Phase 1]